Cardiac biomarkers and COVID-19: A systematic review and meta-analysis심장 바이오 마커 및 Covid-19 : 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-09-012022-08-31 Journal: Journal of infection and public health [Category] 바이오마커, [키워드] 95% CI 95% confidence interval applied Biomarker cardiac Cardiac biomarkers cardiac troponin Cardiac troponin I cardiac troponin T COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients COVID-19 severity creatine creatine kinase Creatine kinase-MB disease disease mortality disease severity evaluate exhibited Google Scholar Meta-analysis Mortality Myoglobin Patient performed reduce Serum level severity SMD standardized mean difference systematic review Treatment troponin I troponin T was used Web of Science [DOI] 10.1016/j.jiph.2021.07.016 PMC 바로가기 [Article Type] Meta-Analysis
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis코로나바이러스 2019(COVID-19)의 중증 질환 및 사망률과 관련된 심장 바이오마커, 심장 손상 및 동반 질환: 체계적인 검토 및 메타 분석Review Published on 2021-08-182022-09-10 Journal: Immunity, Inflammation and Disease [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Acute cardiac injury acute myocardial injury Biomarker Biomarkers cardiac Cardiac biomarkers cardiac injury cardiovascular disease certainty Clinical research clinical trial clinical trials CNKI Cochrane Library Comorbidities Comorbidity coronavirus disease correlation COVID‐19 COVID‐19 patients COVID‐19 creatine creatine kinase Critical event Evidence except for groups help hypertension IMPROVE Injury Laboratory laboratory parameter Laboratory parameters Lactate lactate dehydrogenase LDH mean difference measure medRxiv meta‐analysis Mortality MOST myocardial injury Myoglobin no difference NT‐proBNP Odds ratio outcome outcome measures Patient patients peptide pool Relative risk Research Result risk SARS‐CoV‐2 sensitivity Serum level severe group severity SinoMed SMD systematic review systemically TnI total sample size Treatment troponin I VIP was performed was related Web of Science [DOI] 10.1002/iid3.471 PMC 바로가기 [Article Type] Review
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A ReviewCOVID-19에서 심장 스트레스 및 사이토카인 방출 증후군의 바이오마커: 검토Review Published on 2021-06-012022-09-11 Journal: Current heart failure reports [Category] MERS, SARS, 바이오마커, [키워드] absence acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Biomarkers BNP cardiac Cardiac biomarkers cardiac injury cardiac troponin clinical benefit concerning Coronary artery Coronary artery disease coronavirus Coronavirus 2019 correlated COVID-19 CRS cytokine cytokine release Cytokine release syndrome Cytokines defined Dexamethasone elevated etiology Evidence global pandemic IL-6 Illness severity increased mortality Injury marker myocardial injury myocarditis Obstructive Patient patients hospitalized patients with COVID-19 pattern peptide recent reduce referred to Release Remdesivir respiratory respiratory virus review risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus shown Stress syndrome therapy troponin while [DOI] 10.1007/s11897-021-00505-2 PMC 바로가기 [Article Type] Review
Evaluation of the relation between cardiac biomarkers and thorax computerized tomography findings in COVID-19 patients코로나19 환자의 심장 바이오마커와 흉부 전산화단층촬영소견의 연관성 평가Clinical Trial Published on 2021-01-272022-09-01 Journal: Biomarkers in Medicine [Category] SARS, 바이오마커, 임상, 진단, [키워드] albumin Biomarker C-reactive protein Cardiac biomarkers cardiac troponin Chest computed tomography Computed tomography Computerized tomography consecutive patient COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients COVID-19 pneumonia COVID-19 severity CT finding D-dimer elevated ferritin Lactate lactate dehydrogenase material myocardial injury Patient patients PCR-positive Pneumonia positive progressive disease Quantitative quantitative PCR risk stratification significantly lower Thorax thorax CT troponin troponin I troponin level troponin levels was performed with COVID-19 [DOI] 10.2217/bmm-2020-0388 PMC 바로가기 [Article Type] Clinical Trial
Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac DiseaseCardiovascular Medicine Published on 2021-01-202022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] Admission adverse outcome Analysis association Biomarker cardiac Cardiac biomarkers cardiac disease Characteristics CK-MB clinical collected comparable Concentration Concomitant condition coronavirus disease COVID-19 COVID-19 case died early stage Efficacy enrolled evaluated high risk High-risk patients in-hospital mortality increase Increased increases in Laboratory results laboratory-confirmed late stage Level marker Non-survivors not significant NT-proBNP occur outcome pandemic Patient patients patients with COVID-19 prognostic Prognostic value severity significantly significantly higher significantly increased study population survived the disease value [DOI] 10.3389/fcvm.2020.599096 PMC 바로가기 [Article Type] Cardiovascular Medicine
Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis코로나19 환자에서 울혈성 심부전의 영향과 심장 바이오마커의 역할: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-01-012022-08-31 Journal: Indian heart journal [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Acute cardiac injury appear Biomarker Biomarkers BNP cardiac Cardiac arrhythmia cardiac arrhythmias Cardiac biomarkers cardiac injury cardiovascular comorbidities cardiovascular disease CK-MB collected conducted congestive heart failure coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients database Deceased determined by disease severity elevated Google Scholar hypertension identify Impact in-hospital mortality increased risk mean difference Meta-analysis Mortality mortality risk non-survivor NT-proBNP outcome outcomes Patient paucity of data Prognosis Relative risk reported risk risk factor Risk factors selected severe disease severely infected patients significantly survival systematic review troponin Troponin-I was used [DOI] 10.1016/j.ihj.2020.12.002 PMC 바로가기 [Article Type] Meta-Analysis
Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary ArteritisPediatrics Published on 2020-09-242022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] Abnormalities abnormality acquired heart disease Cardiac biomarkers cardiovascular cardiovascular risk children clinically Complication Coronary Coronary artery dysfunction echocardiography Follow-up increasingly Involvement Kawasaki disease Kawasaki disease shock syndrome myocarditis Patient Pericarditis reported serious complication Shock syndrome valvular [DOI] 10.3389/fped.2020.526969 PMC 바로가기 [Article Type] Pediatrics
Heart failure and COVID-19Article Published on 2020-07-272023-06-16 Journal: Heart failure reviews [Category] MERS, [키워드] Cardiac biomarkers COVID-19 heart failure Hemodynamics [DOI] 10.1007/s10741-020-10008-2 PMC 바로가기 [Article Type] Article
Cardiac manifestations in COVID‐19 patients—A systematic reviewReview Article Published on 2020-07-112022-10-30 Journal: Journal of cardiac surgery [Category] COVID-19, MERS, SARS, [키워드] affecting arrhythmia article association Biomarker cardiac Cardiac biomarkers cardiac manifestations cardiovascular cardiovascular risk factors cardiovascular system clinical implication Clinical outcome Clinical presentations coronavirus correlation country COVID‐19 COVID‐19 patients COVID‐19 database described disease disease severity Escalation global pandemic Google Scholar heart failure help helping identify information Interaction literature review manifestation Manifestations myocarditis Myoglobin NT‐proBNP objective OVID pandemic Patient prognostic Prognostic value respiratory manifestations Result risk factor SARS‐CoV‐2 severe disease Shock systematic review Treatment was performed [DOI] 10.1111/jocs.14808 PMC 바로가기 [Article Type] Review Article
COVID-19 and Heart: From Clinical Features to Pharmacological ImplicationsReview Published on 2020-06-222022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute respiratory syndrome Admission angiotensin-converting enzyme inhibitor Arrhythmias association Cardiac biomarkers cardiological cardiovascular disease cardiovascular diseases China clinical clinical feature Clinical outcome coronavirus coronavirus disease Coronavirus disease 2019 (COVID-19) country COVID-19 COVID-19 patient CVD disease disease severity epidemiological data feature highly pathogenic Hospital admission implication management morbidity and mortality myocardial injury outbreak pandemic Patient pharmacological Prognosis SARS-CoV-2 SARS-COV-2 infection Spread Wuhan, China [DOI] 10.3390/jcm9061944 PMC 바로가기 [Article Type] Review